English

NOVAVAX, INC.

EDGAR

NVAX Current report (8-K) · filed 2026-10-29

Annual consolidated revenue for 2025: about USD 1.123B, using the latest reported figures. The previous period, 2024, was about USD 682.2M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

56.7 million USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 56698000 USD Source

Operating margin

-96.84%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -54906000 USD Source
Revenue: 56698000 USD Source

Operating cash flow

-72.8 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -105200000 USD Source
Operating Cash Flow: -32400000 USD Source

Cash and cash equivalents: 191 million USD 2026-06-30 Source
Exact value

191458000 USD
Long-term debt including current maturities: 291 million USD 2026-06-30 Source
Exact value

291490000 USD
Shares outstanding: 165 million shares 2026-06-30 Source
Exact value

164815529 shares

Reported share-count change

1.64% · 2.66 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

162155109 shares · 2025-06-30· Source
164815529 shares · 2026-06-30· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-29.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2025-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
capital expenditure: No compatible figures in this window
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 11 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
Long-term debt including current maturities: 1 of 11 periods available· newest 2025-12-31
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+64.7%

Prior period

USD 682.16 million

2024-01-01 – 2024-12-31
Current period

USD 1.12 billion

2025-01-01 – 2025-12-31

Exact inputs and evidence

1123479000 − 682162000 = 441317000 USD

682162000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
1123479000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NOVAVAX, INC. · 2025-12-31 NOVAVAX, INC. (edgar:1000694) Year-over-year change in Revenue: 441317000 USD Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1123479000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#2569867 Filing: 000100069426000007 Input fundies:Revenue: 682162000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#2570845 Filing: 000100069426000007
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 627.8 million

Prior period

−USD 187.5 million

2024-01-01 – 2024-12-31
Current period

USD 440.3 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

440300000 − -187499000 = 627799000 USD

-187499000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
440300000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NOVAVAX, INC. · 2025-12-31 NOVAVAX, INC. (edgar:1000694) Year-over-year change in Net income: 627799000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 440300000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1658922 Filing: 000100069426000007 Input fundies:NetIncome: -187499000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1562953 Filing: 000100069426000007
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 157.34 million

Prior period

−USD 87.26 million

2024-01-01 – 2024-12-31
Current period

−USD 244.6 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-244600000 − -87263000 = -157337000 USD

-87263000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-244600000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NOVAVAX, INC. · 2025-12-31 NOVAVAX, INC. (edgar:1000694) Year-over-year change in Operating cash flow: -157337000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -244600000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1659120 Filing: 000100069426000007 Input fundies:OperatingCashFlow: -87263000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1592203 Filing: 000100069426000007
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue USD 1.12 billion 100% of revenue
Cost of revenue USD 73.04 million 6.5% of revenue
Operating expenses USD 499.8 million 44% of revenue
Other operating costs Derived USD 97.85 million 8.7% of revenue
Operating income USD 452.8 million 40% of revenue
Tax, interest and other Derived USD 12.5 million 1.1% of revenue
Net income USD 440.3 million 39% of revenue

Cash

Operating cash flow −USD 244.6 million −22% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2016 Operating loss: operating costs were 1,853% of revenue.
2017 Operating loss: operating costs were 651% of revenue.
2018 Operating loss: operating costs were 607% of revenue.
2019 Operating loss: operating costs were 746% of revenue.
2020 Operating loss: operating costs were 188% of revenue.
2021 Operating loss: operating costs were 247% of revenue.
2022 Operating loss: operating costs were 133% of revenue.
2023 Operating loss: operating costs were 158% of revenue.
2024 Operating loss: operating costs were 136% of revenue.
2025 39%60%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2016 2016-01-01 – 2016-12-31	15353000	284466000 Derived	-269113000	10853000 Derived	-279966000	Unavailable	Source 2016-01-01 – 2016-12-31: 15353000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -269113000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -279966000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -258768000 USD Inspect Operating Cash Flow Open source
2017 2017-01-01 – 2017-12-31	31176000	202886000 Derived	-171710000	12059000 Derived	-183769000	Unavailable	Source 2017-01-01 – 2017-12-31: 31176000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -171710000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -183769000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -144476000 USD Inspect Operating Cash Flow Open source
2018 2018-01-01 – 2018-12-31	34288000	208206000 Derived	-173918000	10830000 Derived	-184748000	Unavailable	Source 2018-01-01 – 2018-12-31: 34288000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -173918000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -184748000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -184825000 USD Inspect Operating Cash Flow Open source
2019 2019-01-01 – 2019-12-31	18662000	139243000 Derived	-120581000	12113000 Derived	-132694000	Unavailable	Source 2019-01-01 – 2019-12-31: 18662000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -120581000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -132694000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -136623000 USD Inspect Operating Cash Flow Open source
2020 2020-01-01 – 2020-12-31	475598000	892317000 Derived	-416719000	1540000 Derived	-418259000	Unavailable	Source 2020-01-01 – 2020-12-31: 475598000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -416719000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -418259000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -42541000 USD Inspect Operating Cash Flow Open source
2021 2021-01-01 – 2021-12-31	1146290000	2832866000 Derived	-1686576000	57175000 Derived	-1743751000	Unavailable	Source 2021-01-01 – 2021-12-31: 1146290000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -1686576000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -1743751000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 322946000 USD Inspect Operating Cash Flow Open source
2022 2022-01-01 – 2022-12-31	1981872000	2626608000 Derived	-644736000	13203000 Derived	-657939000	Unavailable	Source 2022-01-01 – 2022-12-31: 1981872000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -644736000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -657939000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -415937000 USD Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	983705000	1550216000 Derived	-566511000	-21449000 Derived	-545062000	Unavailable	Source 2023-01-01 – 2023-12-31: 983705000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -566511000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -545062000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -713967000 USD Inspect Operating Cash Flow Open source
2024 2024-01-01 – 2024-12-31	682162000	931093000 Derived	-248931000	-61432000 Derived	-187499000	Unavailable	Source 2024-01-01 – 2024-12-31: 682162000 USD Inspect Revenue Open source 2024-01-01 – 2024-12-31: -248931000 USD Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -187499000 USD Inspect Net Income Open source 2024-01-01 – 2024-12-31: -87263000 USD Inspect Operating Cash Flow Open source
2025 2025-01-01 – 2025-12-31	1123479000	670684000 Derived	452795000	12495000 Derived	440300000	Unavailable	Source 2025-01-01 – 2025-12-31: 1123479000 USD Inspect Revenue Open source 2025-01-01 – 2025-12-31: 452795000 USD Inspect Operating Income Open source 2025-01-01 – 2025-12-31: 440300000 USD Inspect Net Income Open source 2025-01-01 – 2025-12-31: -244600000 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.1B 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Revenue	15353000	Revenue: 15353000 Open source
20172017-12-31	Revenue	31176000	Revenue: 31176000 Open source
20182018-12-31	Revenue	34288000	Revenue: 34288000 Open source
20192019-12-31	Revenue	18662000	Revenue: 18662000 Open source
20202020-12-31	Revenue	475598000	Revenue: 475598000 Open source
20212021-12-31	Revenue	1146290000	Revenue: 1146290000 Open source
20222022-12-31	Revenue	1981872000	Revenue: 1981872000 Open source
20232023-12-31	Revenue	983705000	Revenue: 983705000 Open source
20242024-12-31	Revenue	682162000	Revenue: 682162000 Open source
20252025-12-31	Revenue	1123479000	Revenue: 1123479000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

64.7% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Year over year	-57.6%	Revenue: 15353000 Open source Revenue: 36250000 Open source
20172017-12-31	Year over year	103.1%	Revenue: 31176000 Open source Revenue: 15353000 Open source
20182018-12-31	Year over year	10%	Revenue: 34288000 Open source Revenue: 31176000 Open source
20192019-12-31	Year over year	-45.6%	Revenue: 18662000 Open source Revenue: 34288000 Open source
20202020-12-31	Year over year	2,448.5%	Revenue: 475598000 Open source Revenue: 18662000 Open source
20212021-12-31	Year over year	141%	Revenue: 1146290000 Open source Revenue: 475598000 Open source
20222022-12-31	Year over year	72.9%	Revenue: 1981872000 Open source Revenue: 1146290000 Open source
20232023-12-31	Year over year	-50.4%	Revenue: 983705000 Open source Revenue: 1981872000 Open source
20242024-12-31	Year over year	-30.7%	Revenue: 682162000 Open source Revenue: 983705000 Open source
20252025-12-31	Year over year	64.7%	Revenue: 1123479000 Open source Revenue: 682162000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 40.3% 2025

Net margin 39.2% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Operating margin	-1,752.8%	Operating Income: -269113000 Open source Revenue: 15353000 Open source
20172017-12-31	Operating margin	-550.8%	Operating Income: -171710000 Open source Revenue: 31176000 Open source
20182018-12-31	Operating margin	-507.2%	Operating Income: -173918000 Open source Revenue: 34288000 Open source
20192019-12-31	Operating margin	-646.1%	Operating Income: -120581000 Open source Revenue: 18662000 Open source
20202020-12-31	Operating margin	-87.6%	Operating Income: -416719000 Open source Revenue: 475598000 Open source
20212021-12-31	Operating margin	-147.1%	Operating Income: -1686576000 Open source Revenue: 1146290000 Open source
20222022-12-31	Operating margin	-32.5%	Operating Income: -644736000 Open source Revenue: 1981872000 Open source
20232023-12-31	Operating margin	-57.6%	Operating Income: -566511000 Open source Revenue: 983705000 Open source
20242024-12-31	Operating margin	-36.5%	Operating Income: -248931000 Open source Revenue: 682162000 Open source
20252025-12-31	Operating margin	40.3%	Operating Income: 452795000 Open source Revenue: 1123479000 Open source
20162016-12-31	Net margin	-1,823.5%	Net Income: -279966000 Open source Revenue: 15353000 Open source
20172017-12-31	Net margin	-589.5%	Net Income: -183769000 Open source Revenue: 31176000 Open source
20182018-12-31	Net margin	-538.8%	Net Income: -184748000 Open source Revenue: 34288000 Open source
20192019-12-31	Net margin	-711%	Net Income: -132694000 Open source Revenue: 18662000 Open source
20202020-12-31	Net margin	-87.9%	Net Income: -418259000 Open source Revenue: 475598000 Open source
20212021-12-31	Net margin	-152.1%	Net Income: -1743751000 Open source Revenue: 1146290000 Open source
20222022-12-31	Net margin	-33.2%	Net Income: -657939000 Open source Revenue: 1981872000 Open source
20232023-12-31	Net margin	-55.4%	Net Income: -545062000 Open source Revenue: 983705000 Open source
20242024-12-31	Net margin	-27.5%	Net Income: -187499000 Open source Revenue: 682162000 Open source
20252025-12-31	Net margin	39.2%	Net Income: 440300000 Open source Revenue: 1123479000 Open source
20162016-12-31	Free cash flow margin	Not reported	Revenue: 15353000 Open source Operating Cash Flow: -258768000 Open source
20172017-12-31	Free cash flow margin	Not reported	Revenue: 31176000 Open source Operating Cash Flow: -144476000 Open source
20182018-12-31	Free cash flow margin	Not reported	Revenue: 34288000 Open source Operating Cash Flow: -184825000 Open source
20192019-12-31	Free cash flow margin	Not reported	Revenue: 18662000 Open source Operating Cash Flow: -136623000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 475598000 Open source Operating Cash Flow: -42541000 Open source
20212021-12-31	Free cash flow margin	Not reported	Revenue: 1146290000 Open source Operating Cash Flow: 322946000 Open source
20222022-12-31	Free cash flow margin	Not reported	Revenue: 1981872000 Open source Operating Cash Flow: -415937000 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 983705000 Open source Operating Cash Flow: -713967000 Open source
20242024-12-31	Free cash flow margin	Not reported	Revenue: 682162000 Open source Operating Cash Flow: -87263000 Open source
20252025-12-31	Free cash flow margin	Not reported	Revenue: 1123479000 Open source Operating Cash Flow: -244600000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -244.6M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Operating cash flow	-258768000	Operating Cash Flow: -258768000 Open source
20172017-12-31	Operating cash flow	-144476000	Operating Cash Flow: -144476000 Open source
20182018-12-31	Operating cash flow	-184825000	Operating Cash Flow: -184825000 Open source
20192019-12-31	Operating cash flow	-136623000	Operating Cash Flow: -136623000 Open source
20202020-12-31	Operating cash flow	-42541000	Operating Cash Flow: -42541000 Open source
20212021-12-31	Operating cash flow	322946000	Operating Cash Flow: 322946000 Open source
20222022-12-31	Operating cash flow	-415937000	Operating Cash Flow: -415937000 Open source
20232023-12-31	Operating cash flow	-713967000	Operating Cash Flow: -713967000 Open source
20242024-12-31	Operating cash flow	-87263000	Operating Cash Flow: -87263000 Open source
20252025-12-31	Operating cash flow	-244600000	Operating Cash Flow: -244600000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20162016-12-31	Free cash flow	Unavailable	Operating Cash Flow: -258768000 Open source
20172017-12-31	Free cash flow	Unavailable	Operating Cash Flow: -144476000 Open source
20182018-12-31	Free cash flow	Unavailable	Operating Cash Flow: -184825000 Open source
20192019-12-31	Free cash flow	Unavailable	Operating Cash Flow: -136623000 Open source
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -42541000 Open source
20212021-12-31	Free cash flow	Unavailable	Operating Cash Flow: 322946000 Open source
20222022-12-31	Free cash flow	Unavailable	Operating Cash Flow: -415937000 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -713967000 Open source
20242024-12-31	Free cash flow	Unavailable	Operating Cash Flow: -87263000 Open source
20252025-12-31	Free cash flow	Unavailable	Operating Cash Flow: -244600000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

110.9% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Liabilities / assets	101.4%	Total Liabilities: 399847000 Open source Total Assets: 394301000 Open source
20172017-12-31	Liabilities / assets	133.6%	Total Liabilities: 404225000 Open source Total Assets: 302493000 Open source
20182018-12-31	Liabilities / assets	180.7%	Total Liabilities: 375913000 Open source Total Assets: 207978000 Open source
20192019-12-31	Liabilities / assets	207.6%	Total Liabilities: 358974000 Open source Total Assets: 172957000 Open source
20202020-12-31	Liabilities / assets	60.4%	Total Liabilities: 955270000 Open source Total Assets: 1582479000 Open source
20212021-12-31	Liabilities / assets	113.6%	Total Liabilities: 2928426000 Open source Total Assets: 2576753000 Open source
20222022-12-31	Liabilities / assets	128.1%	Total Liabilities: 2892757000 Open source Total Assets: 2258679000 Open source
20232023-12-31	Liabilities / assets	139.9%	Total Liabilities: 2514417000 Open source Total Assets: 1797490000 Open source
20242024-12-31	Liabilities / assets	140%	Total Liabilities: 2184259000 Open source Total Assets: 1560418000 Open source
20252025-12-31	Liabilities / assets	110.9%	Total Liabilities: 1304265000 Open source Total Assets: 1176512000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.13× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20162016-12-31	Current assets / current liabilities	4.33×	Current Assets: 287830000 Open source Current Liabilities: 66406000 Open source
20172017-12-31	Current assets / current liabilities	2.76×	Current Assets: 203311000 Open source Current Liabilities: 73675000 Open source
20182018-12-31	Current assets / current liabilities	2.62×	Current Assets: 119276000 Open source Current Liabilities: 45539000 Open source
20192019-12-31	Current assets / current liabilities	3.77×	Current Assets: 97247000 Open source Current Liabilities: 25795000 Open source
20202020-12-31	Current assets / current liabilities	2.15×	Current Assets: 1248203000 Open source Current Liabilities: 579672000 Open source
20212021-12-31	Current assets / current liabilities	0.9×	Current Assets: 2155119000 Open source Current Liabilities: 2390319000 Open source
20222022-12-31	Current assets / current liabilities	0.69×	Current Assets: 1703391000 Open source Current Liabilities: 2459944000 Open source
20232023-12-31	Current assets / current liabilities	0.7×	Current Assets: 1143888000 Open source Current Liabilities: 1635138000 Open source
20242024-12-31	Current assets / current liabilities	0.98×	Current Assets: 1128942000 Open source Current Liabilities: 1154416000 Open source
20252025-12-31	Current assets / current liabilities	2.13×	Current Assets: 978276000 Open source Current Liabilities: 459950000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 279.97 million Exact value Exact value: -279966000 USD 2016-01-01 – 2016-12-31: -279966000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2016-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -279966000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -279966000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000114420419014640/nvax-20181231.xml#124398 Filing: 000114420419014640 The citation records this snapshot. The page link may show a newer release later.	−USD 258.77 million Exact value Exact value: -258768000 USD 2016-01-01 – 2016-12-31: -258768000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2016-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -258768000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -258768000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000114420419014640/nvax-20181231.xml#160880 Filing: 000114420419014640 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 183.77 million Exact value Exact value: -183769000 USD 2017-01-01 – 2017-12-31: -183769000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2017-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -183769000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -183769000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000114420419014640/nvax-20181231.xml#124250 Filing: 000114420419014640 The citation records this snapshot. The page link may show a newer release later.	−USD 144.48 million Exact value Exact value: -144476000 USD 2017-01-01 – 2017-12-31: -144476000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2017-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -144476000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -144476000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000114420419014640/nvax-20181231.xml#154355 Filing: 000114420419014640 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 184.75 million Exact value Exact value: -184748000 USD 2018-01-01 – 2018-12-31: -184748000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2018-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -184748000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -184748000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069421000004/nvax-20201231.htm#2202634 Filing: 000100069421000004 The citation records this snapshot. The page link may show a newer release later.	−USD 184.83 million Exact value Exact value: -184825000 USD 2018-01-01 – 2018-12-31: -184825000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2018-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -184825000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -184825000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069421000004/nvax-20201231.htm#1440187 Filing: 000100069421000004 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 132.69 million Exact value Exact value: -132694000 USD 2019-01-01 – 2019-12-31: -132694000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2019-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -132694000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -132694000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069422000004/nvax-20211231.htm#1533712 Filing: 000100069422000004 The citation records this snapshot. The page link may show a newer release later.	−USD 136.62 million Exact value Exact value: -136623000 USD 2019-01-01 – 2019-12-31: -136623000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2019-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -136623000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -136623000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069422000004/nvax-20211231.htm#1563783 Filing: 000100069422000004 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 418.26 million Exact value Exact value: -418259000 USD 2020-01-01 – 2020-12-31: -418259000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2020-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -418259000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -418259000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069423000005/nvax-20221231.htm#1593515 Filing: 000100069423000005 The citation records this snapshot. The page link may show a newer release later.	−USD 42.54 million Exact value Exact value: -42541000 USD 2020-01-01 – 2020-12-31: -42541000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2020-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -42541000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -42541000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069423000005/nvax-20221231.htm#1626718 Filing: 000100069423000005 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 1.74 billion Exact value Exact value: -1743751000 USD 2021-01-01 – 2021-12-31: -1743751000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2021-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -1743751000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1743751000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069424000007/nvax-20231231.htm#1549902 Filing: 000100069424000007 The citation records this snapshot. The page link may show a newer release later.	USD 322.95 million Exact value Exact value: 322946000 USD 2021-01-01 – 2021-12-31: 322946000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2021-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: 322946000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 322946000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069424000007/nvax-20231231.htm#1573275 Filing: 000100069424000007 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	−USD 657.94 million Exact value Exact value: -657939000 USD 2022-01-01 – 2022-12-31: -657939000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2022-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -657939000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -657939000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069425000004/nvax-20241231.htm#1487971 Filing: 000100069425000004 The citation records this snapshot. The page link may show a newer release later.	−USD 415.94 million Exact value Exact value: -415937000 USD 2022-01-01 – 2022-12-31: -415937000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2022-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -415937000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -415937000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069425000004/nvax-20241231.htm#1513349 Filing: 000100069425000004 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 545.06 million Exact value Exact value: -545062000 USD 2023-01-01 – 2023-12-31: -545062000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2023-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -545062000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -545062000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1563726 Filing: 000100069426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 713.97 million Exact value Exact value: -713967000 USD 2023-01-01 – 2023-12-31: -713967000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2023-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -713967000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -713967000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1592861 Filing: 000100069426000007 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 187.5 million Exact value Exact value: -187499000 USD 2024-01-01 – 2024-12-31: -187499000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2024-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: -187499000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -187499000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1562953 Filing: 000100069426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 87.26 million Exact value Exact value: -87263000 USD 2024-01-01 – 2024-12-31: -87263000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2024-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -87263000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -87263000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1592203 Filing: 000100069426000007 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	USD 440.3 million Exact value Exact value: 440300000 USD 2025-01-01 – 2025-12-31: 440300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NOVAVAX, INC. · 2025-12-31 NOVAVAX, INC. (edgar:1000694) Net Income: 440300000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 440300000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1658922 Filing: 000100069426000007 The citation records this snapshot. The page link may show a newer release later.	−USD 244.6 million Exact value Exact value: -244600000 USD 2025-01-01 – 2025-12-31: -244600000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NOVAVAX, INC. · 2025-12-31 NOVAVAX, INC. (edgar:1000694) Operating Cash Flow: -244600000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:43:02Z Snapshot: 212e25b7be2df1f7925f2363feaeb0beec06f956322c607eaa1e38d0ad10db60 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1000694/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -244600000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1000694/000100069426000007/nvax-20251231.htm#1659120 Filing: 000100069426000007 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

171 filings · 5,091 latest values · 5,091 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001000694, 1000694, NVAX, edgar:1000694

Also known as NOVAVAX INC, NOVAVAX INC., NOVAVAX, INC, NOVAVAX, INC., NOVAVAX, INC, NOVAVAX, INC.

NOVAVAX, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation